Prevalence of Antibodies to Epstein-Barr Virus Nuclear Antigen 2B in Persons Infected with the Human Immunodeficiency Virus

Autor: Sculley, T. B., Cross, S. M., Borrow, P., Cooper, David A.

Publikováno v: The Journal of Infectious Diseases, 1988 Jul 01. 158(1), 186-192.

Externí odkaz: https://www.jstor.org/stable/30136294

Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.

Autor: Silins, S L, Cross, S M, Elliott, S L, Pye, S J, Burrows, J M, Moss, D J, Misko, I S

Publikováno v: International Immunology; Nov1997, Vol. 9 Issue 11, p1745-1755, 11p

Purine Synthesis De Novo in Lymphocytes from Patients with Gout

Autor: Gordon, R. B., Counsilman, A. C., Cross, S. M. C., Emmerson, B. T.

Publikováno v: Clinical Science; November 1982, Vol. 63 Issue: 5 p429-435, 7p

Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.

Autor: Silins SL; Infectious Disease and Immunology Division, Queensland Institute of Medical Research, Herston, Australia. sharons@qimr.edu.au, Sherritt MA, Silleri JM, Cross SM, Elliott SL, Bharadwaj M, Le TT, Morrison LE, Khanna R, Moss DJ, Suhrbier A, Misko IS

Publikováno v: Blood [Blood] 2001 Dec 15; Vol. 98 (13), pp. 3739-44.

A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.

Autor: Silins SL; Epstein-Barr Virus Unit, Queensland Institute of Medical Research and University of Queensland Joint Oncology Program, Brisbane, Queensland, Australia 4029. sharonS@qimr.edu.au, Cross SM, Krauer KG, Moss DJ, Schmidt CW, Misko IS

Publikováno v: The Journal of clinical investigation [J Clin Invest] 1998 Oct 15; Vol. 102 (8), pp. 1551-8.